Asparagus Capsule Consumption and Blood Sugar and Lipids and Oxidative Stress

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-20

Study Completion Date

2023-09-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Types of Starch and Their Effect on Blood Glucose, Appetite and Food Intake

NCT00980941

Obesity Prevention Diabetes Prevention

COMPLETED NA

Studying the Effect of Capsinoids on Brown Fat Using Infrared Thermal Imaging.

NCT01961674

Obesity Diabetes Impaired Glucose Tolerance

COMPLETED NA

Effect of Beverages Containing Different Doses of Alginate Fibers on Appetite, Energy Intake and Glycemia

NCT01720784

Obesity

COMPLETED NA

Effects of D-allulose (Psicose) With Sucrose Beverage on Glucose Tolerance and Insulin Level

NCT02455934

Impaired Glucose Tolerance

COMPLETED NA

Types of Starch and Their Effect on Blood Glucose, Appetite and Food Intake

NCT00988689

Obesity Prevention Diabetes Prevention

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design was cross-sectional. Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels. Analysis of covariance was used to analyze parameters between groups and paired t-test was used to analyze parameters intra-group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asparagus Capsule Consumption

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomly divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups.

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asparagus capsule

Participants were randomized to receive an arm. In this arm, participants received asparagus capsule and were asked to consume at 40 mg/kg (1-2 capsule) within 15-30 min after breakfast. Consumption was taken at participants' dwelling.

Group Type EXPERIMENTAL

Asparagus capsule

Intervention Type DIETARY_SUPPLEMENT

Asparagus capsule is categorized as dietary supplement.

Placebo capsule

Participants were randomized to receive an arm. In this arm, participants received placebo capsule and were asked to consume at 40 mg/kg (1-2 capsule) within 15-30 min after breakfast. Consumption was taken at participants' dwelling.

Group Type PLACEBO_COMPARATOR

Placebo capsule

Intervention Type OTHER

Placebo capsule is categorized as other.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Asparagus capsule

Asparagus capsule is categorized as dietary supplement.

Intervention Type DIETARY_SUPPLEMENT

Placebo capsule

Placebo capsule is categorized as other.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or woman, aged between 18 to 59 years
* Body mass index more than 23 (Asian criteria)
* No history of hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer
* No regular intake of dietary supplements, i.e., vitamins, antioxidants
* No regular smokers or alcohol drinkers (\>2 times per week)
* Not sportman or regular exerciser (\>2 times per week or \>150 min per week)
* No food allergy, especially shoot